微可素p2的化学优化和衍生以向多种细菌感染:来自类的新型抗生素
Jiyun Park1, Dahyun Kim2, Young-Jin Son2
1Department of Microbiology, Institute for Immunology and Immunological Disease, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
World journal of microbiology & biotechnology
|August 20, 2024
概括
新的铁类抗生素对抗耐药细菌显示出有前途. 微素P2 (MP2) 的衍生物对Mycobacterium avium复合体 (MAC),Clostridioides difficile和耐甲西林金黄色葡萄球菌 (MRSA) 有效.
科学领域:
- 药用化学 医学化学
- 抗微生物药物发现发现
- 计算化学计算化学
背景情况:
- 抗菌素耐药性 (AMR) 是一个全球性的健康危机,需要新型抗生素的开发.
- 类,像微可P2 (MP2),对包括耐药菌株在内的格兰阳性病原体和真菌细菌有很强的作用.
- 之前在硫合成中的局限性阻碍了临床翻译的结构-活性关系 (SAR) 研究.
研究的目的:
- 为微素P2 (MP2) 和其衍生物开发高效的合成途径.
- 通过药物化学和计算模拟来改善MP2衍生物的类似药物的特性.
- 识别和评估针对具有挑战性的病原体的基于硫的新型抗感染剂.
主要方法:
- 开发MP2和类似的高效合成平台.
- 利用计算分子动态模拟来指导药物化学的努力.
- 进行了体外研究,以评估新型化合物的抗菌活性和类似药物的特性.
主要成果:
- 鉴定出AJ-037和AJ-206的化合物,它们对Mycobacterium avium复合体 (MAC) 具有强烈的活性.
- 开发了临床前候选药物AJ-024用于Clostridioides difficile和AJ-147用于MRSAimpetigo.
- AJ-147与当前的治疗方法进行了有利的比较,并减少了促炎性细胞因子.
结论:
- 有效的合成途径和药物化学已经产生了有前途的硫类候选药物.
- 新型酸衍生物显示出治疗MAC,C. difficile和MRSA感染的巨大潜力.
- 这些化合物有利于进一步的临床开发,以对抗抗菌素耐药性.
相关概念视频
Antibiotic Selection
Overview
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Biological Methods for Microbial Control
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...


